Finerenone consistently reduces heart failure events and cardiovascular death regardless of ischemic heart disease history, according to the FINEARTS-HF trial.
Jawad Butt, MD, PhD
Advertisement
Articles by Jawad Butt, MD, PhD
Jawad Butt, MD, offers insight into his analysis of the FINEARTS-HF trial.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
First-Ever Guideline on Cardio-Kidney-Metabolic Syndrome Calls for Earlier Screening, Coordinated Care
2
How the Chai Discovery–Eli Lilly Collaboration Could Advance the Future of AI-Driven Biologics Development
3
GLP-1 Counseling Pearls: 7 Things Every Pharmacist Should Know
4
Anticoagulation in AFib: Risk Stratification, Therapy Selection, and Factor XI Inhibitors
5